At Synergy,

we’re challenging the status quo in gastrointestinal (GI) medicine to develop new treatments that offer the potential to change people’s lives.

An Innovative Approach

An Innovative Approach

Our proprietary GI platform is based on uroguanylin, a naturally occurring human GI peptide that plays an important role in supporting normal bowel function.

Learn More

Latest News

Recent Event:
Rodman & Renshaw 18th Annual Global Investment Conference

Sep 12, 2016 • 5:30PM EDT

View All Press Releases

Executive Leadership

Our leadership team of seasoned research scientists, clinicians, and executives has extensive research and commercial experience both in the biopharmaceutical industry and the GI category.

Learn More